144 related articles for article (PubMed ID: 11805430)
1. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
Horm Res; 2001; 55(6):271-7. PubMed ID: 11805430
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
4. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
[TBL] [Abstract][Full Text] [Related]
5. Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
Yoon YA; Woo S; Kim MS; Kim B; Choi YJ
Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):216-221. PubMed ID: 36854385
[TBL] [Abstract][Full Text] [Related]
6. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
Anandi VS; Shaila B
J Pediatr Endocrinol Metab; 2017 May; 30(6):677-681. PubMed ID: 28489558
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.
Pauwels G; Allegaert K; Régal L; Meulemans A
Acta Clin Belg; 2012; 67(2):88-93. PubMed ID: 22712163
[TBL] [Abstract][Full Text] [Related]
10. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia.
Pode-Shakked N; Blau A; Pode-Shakked B; Tiosano D; Weintrob N; Eyal O; Zung A; Levy-Khademi F; Tenenbaum-Rakover Y; Zangen D; Gillis D; Pinhas-Hamiel O; Loewenthal N; de Vries L; Landau Z; Rachmiel M; Abu-Libdeh A; Eliakim A; Strich D; Koren I; German A; Sack J; Almashanu S
J Clin Endocrinol Metab; 2019 Aug; 104(8):3172-3180. PubMed ID: 30865229
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
12. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
13. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
14. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
16. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
17. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
18. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
19. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
20. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
